TransCode Therapeutics financial statements
트랜스코드 테라퓨틱스NASDAQ:RNAZ · Nasdaq · Healthcare · sector #17$1.78+1.14%
2026-10-06 closeTransCode Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$16M.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy